N/A
Completed N=15
Human Papillomatosis Genotyping of Children in Thailand
Recurrent Laryngeal Papillomatosis · Human Papilloma Virus
Source: ClinicalTrials.gov NCT01304966 ↗
Enrolled (actual)
15
Serious AEs
—
Results posted
Feb 2014
Primary outcomePrimary: Human Papillomavirus Genotypes — 6; 9 participants
Summary
The purpose of the present study was to identify risk factors for more severe juvenile Recurrent Respiratory Papillomatosis (RRP) through prospective evaluation of a pediatric population in Thailand by the employing a protocol that includes staging of disease severity using above mentioned staging system at the time of each endoscopic debridement, as well as human papilloma virus (HPV) genotyping.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Human Papillomavirus Genotypes |
6; 9 | — |
| SECONDARY Cotreta-Derkay Score |
13.83; 27.44 | 0.013 sig |
Eligibility Criteria
Inclusion Criteria
- Patients have active laryngeal papillomatosis .
- Patients have developed this infection before the age of 18 years old.
Exclusion Criteria
- Children whose families do not sign an informed consent to enter into study.
- Children whose families anticipate discontinuing care at a participating institution during the study period.
Data sourced from ClinicalTrials.gov (NCT01304966). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.